|
More
Contract Manufacturing
Research Library
|
|
SafeBridge Consultants, Inc.
|
It is a universal truth that research, development manufacture and formulation of potent active pharmaceutical ingredients (APIs) and products requires both “hardware” ( facilities, equipment and engineering controls) and “software” (programs, practices and procedures) to adequately protect personnel and the environment. When employing third party contracting organizations, there is a need to ...
|
|
|
Patheon Inc.
|
In an era characterized by the need to continuously evaluate and bolster R&D pipelines, the increasing complexity and overall cost to develop and approve drug products, the trend toward genericization, and mounting pressures to both decrease prices and maximize profitability, the pharmaceutical industry has sought competitive advantage in lower cost manufacturing jurisdictions.
The ...
|
|
|
Hyaluron - A Subsidiary of AMRI
|
The advent of bubble elimination in a prefilled syringe offers many advantages worth exploring prior to deciding how a product is to be packaged for clinical studies or commercial distribution. This technique further enhances the benefits of prefilled syringes. Prefilled syringes vs. vials have become the container of choice for parenteral drug delivery. The increase in their use is directly ...
|
|
|
Jameson Publishing, Inc.
|
The current financial crisis, increasing global competition, and near patent expiry of several multibillion dollar drugs is fundamentally reshaping the pharmaceutical industry. As consolidation in the industry continues through merger and acquisitions, companies are being forced to examine new strategies to cut costs and improve efficiencies to adapt to new financial realities. To that end, ...
|
|
|
Hyaluron - A Subsidiary of AMRI
|
Pre-filled syringes are quickly becoming a viable alternative to vials. Review the benefits they offer, including reduced overfill requirements, decreased waste and enhanced product differentiation.
Prefilled syringes are a fast- growing alternative to vials in the parenteral product market due to the many advantages they offer relative to vials. These include reduced overfill requirements, ...
|
|
|
|
